Stock Alert: Emergent BioSolutions Climbs 5%

(RTTNews) - Shares of Emergent BioSolutions Inc. (EBS) are up more than 5% Friday morning. The stock is at $59.41. It has traded in the range of $39.11- $71.19 in the last 52-weeks.

The stock has been rising on the news of it starting the development of two product candidates for the treatment and prevention of coronavirus disease (COVID-19), announced on March 11. Since then, the stock has risen 13%.

Human polyclonal hyperimmune with antibodies to SARS-CoV-2 (COVID-HIG) is being developed as a potential treatment for severe hospitalized patients and protection for at-risk individuals, and Equine-derived polyclonal hyperimmune with antibodies to SARS-CoV-2 (COVID-EIG) is being developed as a potential treatment for severe hospitalized patients.

These product candidates are being developed on Emergent's proprietory hyperimmune platforms.